financetom
Business
financetom
/
Business
/
BMO Raises Rogers Communication Target to $57
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BMO Raises Rogers Communication Target to $57
Jul 2, 2025 10:13 AM

12:45 PM EDT, 07/02/2025 (MT Newswires) -- BMO has increased its target on Rogers Communications to $57 and reiterated its Outperform rating.

Analyst Tim Casey writes that the wireless pricing environment appears to be improving with operators raising prices in April and largely maintaining those levels through the quarter.

Modest Cable revenue growth should also return for the balance of 2025E, Casey adds. The $7 billion structured equity transaction was completed and the MLSE transaction is also expected to be finalized soon. Rogers' sports assets provide significant upside potential.

Price: 42.88, Change: +2.49, Percent Change: +6.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Currenc Group Shares Wednesday?
What's Going On With Currenc Group Shares Wednesday?
Jan 8, 2025
Currenc Group Inc. ( CURR ) shares are trading higher on Wednesday after the company announced the launch of its SEAMLESS Artificial Intelligence (AI) Call Center. The Details: The AI call center is designed to increase efficiency for financial institutions, telecommunications companies, government agencies, cryptocurrency exchanges and other types of institutions by providing them with three distinct software products. Currenc...
Catalyst Pharmaceuticals Reaches Settlement With Teva in Firdapse Patent Litigation
Catalyst Pharmaceuticals Reaches Settlement With Teva in Firdapse Patent Litigation
Jan 8, 2025
01:15 PM EST, 01/08/2025 (MT Newswires) -- Catalyst Pharmaceuticals ( CPRX ) and its licensor SERB have reached a settlement agreement with Teva Pharmaceuticals USA and Teva Pharmaceuticals (TEVA) to resolve the Firdapse patent litigation, Catalyst said Wednesday. Under the terms of the settlement, Teva will not market its generic version of Firdapse in the US any earlier than Feb....
Looking At Caterpillar's Recent Unusual Options Activity
Looking At Caterpillar's Recent Unusual Options Activity
Jan 8, 2025
Financial giants have made a conspicuous bullish move on Caterpillar ( CAT ). Our analysis of options history for Caterpillar ( CAT ) revealed 23 unusual trades. Delving into the details, we found 39% of traders were bullish, while 34% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $611,787, and 15...
Update: Market Chatter: JPMorgan Files Additional Lawsuits Over Greek Fintech Investment
Update: Market Chatter: JPMorgan Files Additional Lawsuits Over Greek Fintech Investment
Jan 8, 2025
01:25 PM EST, 01/08/2025 (MT Newswires) -- (Updates with Viva CEO's statement in sixth and seventh paragraphs.) JPMorgan ( JPM ) filed two additional lawsuits in connection with its investment in Greek fintech Viva Wallet, Bloomberg reported Wednesday. A lawsuit filed in Greece, which asserts a claim of 916 million euros ($944.9 million), alleged that Viva Chief Executive Officer Haris...
Copyright 2023-2025 - www.financetom.com All Rights Reserved